Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Abstract

The US Centers for Disease Control and Prevention (CDC) supports international partners in introducing vaccines, including those against SARS-CoV-2 virus. CDC contributes to the development of global technical tools, guidance, and policy for COVID-19 vaccination and has established its COVID-19 International Vaccine Implementation and Evaluation (CIVIE) program. CIVIE supports ministries of health and their partner organizations in developing or strengthening their national capacities for the planning, implementation, and evaluation of COVID-19 vaccination programs. CIVIE's 7 priority areas for country-specific technical assistance are vaccine policy development, program planning, vaccine confidence and demand, data management and use, workforce development, vaccine safety, and evaluation. We discuss CDC's work on global COVID-19 vaccine implementation, including priorities, challenges, opportunities, and applicable lessons learned from prior experiences with Ebola, influenza, and meningococcal serogroup A conjugate vaccine introductions.

Keywords: COVID-19; Ebola; SARS-CoV-2; coronavirus disease; evaluation; implementation; influenza; meningococcus; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccines; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Green shading indicates the 55 countries supported by the Centers for Disease Control and Prevention’s COVID-19 International Vaccine Implementation and Evaluation program in fiscal year 2021.
Figure 2
Figure 2
Technical areas of support provided to countries by the Centers for Disease Control and Prevention’s COVID-19 International Vaccine Implementation and Evaluation (CIVIE) program in fiscal year 2021
See this image and copyright information in PMC

References

    1. UK Coronavirus Dashboard. Coronavirus (COVID-19) in the UK—vaccinations. 2021. [cited 2021 Sep 2]. https://coronavirus.data.gov.uk/details/vaccinations
    1. Painter EM, Ussery EN, Patel A, Hughes MM, Zell ER, Moulia DL, et al. Demographic characteristics of persons vaccinated during the first month of the COVID-19 vaccination program—United States, December 14, 2020–January 14, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:174–7. 10.15585/mmwr.mm7005e1 - DOI - PMC - PubMed
    1. World Health Organization. Interim recommendations for use of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, under emergency use listing: interim guidance, 8 January 2021. 2021. [cited 2021 Sep 2]. https://apps.who.int/iris/handle/10665/338484
    1. World Health Organization. WHO coronavirus (COVID-19) dashboard. 2022. [cited 2022 Apr 4]. https://covid19.who.int
    1. World Health Organization. Coronavirus disease (COVID-19). WHO—prequalification of medical products. 2022. [cited 2022 Apr 4]. https://extranet.who.int/pqweb/vaccines/covid-19-vaccines